ArticleActa pharmaceutica Sinica. B2024

Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis.

Qian Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.